U.S. Court of Appeals for the Federal Circuit, 2025

Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited

Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited
U.S. Court of Appeals for the Federal Circuit · Decided November 5, 2025
Supernus Pharmaceuticals, Inc. v. Ajanta Pharma Limited

Opinion

Case: 24-1606 Document: 49 Page: 1 Filed: 11/05/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

SUPERNUS PHARMACEUTICALS, INC.,

Plaintiff-Appellee v.

AJANTA PHARMA LIMITED, AJANTA PHARMA

USA INC.,

Defendants

TORRENT PHARMA INC., TORRENT

PHARMACEUTICALS LTD.,

Defendants-Appellants ______________________

2024-1606 ______________________

Appeal from the United States District Court for the District of New Jersey in Nos. 3:21-cv-06964-GC-DEA, 3:21-cv-14268-GC-DEA, Judge Georgette Castner. ______________________

ORDER

The parties, having so agreed,

IT IS ORDERED THAT: Case: 24-1606 Document: 49 Page: 2 Filed: 11/05/2025

2 SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED

The above-captioned appeal is dismissed under Fed. R. App. P. 42(b) with each side to bear their own costs.

FOR THE COURT

November 5, 2025

Date

ISSUED AS A MANDATE: November 5, 2025

Case-law data current through September 30, 2026. Source: CourtListener bulk data.